As of 2026-08-24, Nexalin Technology, Inc. Common Stock (NXL) has a 3-month relative strength percentile of 23 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.3%, relative volume 1.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NXL is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -17.5% / -42.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
NXL appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $44K notional.
Held by 1 ETFs · $44K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $44K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NXL Jan avg: 8.98% median: 3.97% win: 75% σ: 23.27% n: 4 2022-09-19 → 2026-07-31 | NXL Feb avg: -13.03% median: -13.70% win: 0% σ: 4.71% n: 4 2022-09-19 → 2026-07-31 | NXL Mar avg: 71.82% median: -18.00% win: 25% σ: 186.50% n: 4 2022-09-19 → 2026-07-31 | NXL Apr avg: 1.78% median: 2.25% win: 75% σ: 6.54% n: 4 2022-09-19 → 2026-07-31 | NXL May avg: -3.07% median: -14.86% win: 50% σ: 55.58% n: 4 2022-09-19 → 2026-07-31 | NXL Jun avg: 20.61% median: -6.54% win: 50% σ: 83.09% n: 4 2022-09-19 → 2026-07-31 | NXL Jul avg: -9.43% median: -4.06% win: 50% σ: 15.92% n: 4 2022-09-19 → 2026-07-31 | NXL Aug avg: -23.09% median: -19.90% win: 0% σ: 20.50% n: 3 2022-09-19 → 2026-07-31 (current) | NXL Sep avg: -21.18% median: -15.74% win: 0% σ: 23.65% n: 4 2022-09-19 → 2026-07-31 | NXL Oct avg: 84.46% median: 49.83% win: 75% σ: 131.77% n: 4 2022-09-19 → 2026-07-31 | NXL Nov avg: 33.39% median: 46.85% win: 75% σ: 43.30% n: 4 2022-09-19 → 2026-07-31 | NXL Dec avg: -36.63% median: -41.15% win: 25% σ: 30.33% n: 4 2022-09-19 → 2026-07-31 |